115 related articles for article (PubMed ID: 31042009)
1. Evaluation of cytokeratin 19 as a prognostic tumoral and metastatic marker with focus on improved detection methods.
Mehrpouya M; Pourhashem Z; Yardehnavi N; Oladnabi M
J Cell Physiol; 2019 Dec; 234(12):21425-21435. PubMed ID: 31042009
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors.
Menz A; Bauer R; Kluth M; Marie von Bargen C; Gorbokon N; Viehweger F; Lennartz M; Völkl C; Fraune C; Uhlig R; Hube-Magg C; De Wispelaere N; Minner S; Sauter G; Kind S; Simon R; Burandt E; Clauditz T; Lebok P; Jacobsen F; Steurer S; Wilczak W; Krech T; Marx AH; Bernreuther C
Hum Pathol; 2021 Sep; 115():19-36. PubMed ID: 34102222
[TBL] [Abstract][Full Text] [Related]
3. CK7/CK19 index: A potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patients.
Liu LZ; Yang LX; Zheng BH; Dong PP; Liu XY; Wang ZC; Zhou J; Fan J; Wang XY; Gao Q
J Surg Oncol; 2018 Jun; 117(7):1531-1539. PubMed ID: 29513894
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 19 expression in intrathoracic neoplasms: First study utilizing cellblocks, evaluating the role of a rarely used cytokeratin for lung cancers.
Verma V; Rao RN
Diagn Cytopathol; 2022 Mar; 50(3):105-111. PubMed ID: 34981674
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin 19 (CK19) expression by thyroid neoplasms in a Nigerian tertiary health centre.
Idowu SA; Olaniyi OO; Oluwole KA
Pan Afr Med J; 2023; 44():176. PubMed ID: 37455890
[TBL] [Abstract][Full Text] [Related]
7. Combination with CK19 Might Increase the Prognostic Power of Hep Par 1 in Hepatocellular Carcinoma after Curative Resection.
Jin Y; Liang ZY; Zhou WX; Zhou L
J Invest Surg; 2018 Oct; 31(5):412-419. PubMed ID: 28758812
[TBL] [Abstract][Full Text] [Related]
8. Significance of Matrix Metalloproteinase 9 Expression as Supporting Marker to Cytokeratin 19 mRNA in Sentinel Lymph Nodes in Breast Cancer Patients.
Murawski M; Woźniak M; Duś-Szachniewicz K; Kołodziej P; Rzeszutko M; Ziółkowski P
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110764
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin 19 expression in early oral squamous cell carcinoma and their metastasis: Inadequate biomarker for one-step nucleic acid amplification implementation in sentinel lymph node biopsy procedure.
Noorlag R; van Es RJJ; de Bree R; Willems SM
Head Neck; 2017 Sep; 39(9):1864-1868. PubMed ID: 28644540
[TBL] [Abstract][Full Text] [Related]
10. KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markers.
Zhang L; Smyrk TC; Oliveira AM; Lohse CM; Zhang S; Johnson MR; Lloyd RV
Am J Surg Pathol; 2009 Oct; 33(10):1562-9. PubMed ID: 19574886
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
Chung GE; Lee JH; Yoon JH; Myung SJ; Lee K; Jang JJ; Lee JM; Kim SH; Suh KS; Kim YJ; Lee HS
Abdom Imaging; 2012 Jun; 37(3):439-46. PubMed ID: 21584634
[TBL] [Abstract][Full Text] [Related]
12. Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer.
Fujita Y; Terashima M; Hoshino Y; Ohtani S; Kashimura S; Kanzaki N; Osuka F; Kogure M; Gotoh M
Gastric Cancer; 2006; 9(4):308-14. PubMed ID: 17235634
[TBL] [Abstract][Full Text] [Related]
13. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer.
Alix-Panabières C; Vendrell JP; Slijper M; Pellé O; Barbotte E; Mercier G; Jacot W; Fabbro M; Pantel K
Breast Cancer Res; 2009; 11(3):R39. PubMed ID: 19549321
[TBL] [Abstract][Full Text] [Related]
14. [Expression of cytokeratin(CK)7, CK8/18, CK19 and p40 in esophageal squamous cell carcinoma and their correlation with prognosis].
Yang ZY; Zhang HY; Wang F; Ma YH; Li YY; He HL; Wang C; Li SS
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):834-839. PubMed ID: 30423606
[No Abstract] [Full Text] [Related]
15. Cytokeratin 19 regulates endoplasmic reticulum stress and inhibits ERp29 expression via p38 MAPK/XBP-1 signaling in breast cancer cells.
Bambang IF; Lu D; Li H; Chiu LL; Lau QC; Koay E; Zhang D
Exp Cell Res; 2009 Jul; 315(11):1964-74. PubMed ID: 19265690
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
Abouhashem NS; Talaat SM
Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
[TBL] [Abstract][Full Text] [Related]
17. Expression of cytokeratin 19 and protein p63 in fine needle aspiration biopsy of papillary thyroid carcinoma.
Bonzanini M; Amadori PL; Sagramoso C; Dalla Palma P
Acta Cytol; 2008; 52(5):541-8. PubMed ID: 18833815
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytokeratin-19 (CK19) in the classical subtype of papillary thyroid carcinoma: the experience of one center in the Silesian region.
Kaliszewski K; Diakowska D; Strutynska-Karpinska M; Rzeszutko M; Grzegrzolka J; Dziegiel P; Wojtczak B; Sutkowski K
Folia Histochem Cytobiol; 2016; 54(4):193-201. PubMed ID: 28051274
[TBL] [Abstract][Full Text] [Related]
19. Postoperative dynamic changes in the concentration of CK19-2G2 in lung cancer patients and the clinical value of this marker.
Gao J; Lv F; Wang J; Wu Z; Li J; Yan C; Qi J
Tumour Biol; 2015 Nov; 36(11):8295-9. PubMed ID: 26002573
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
